Kwi Man KANG,Young Joon PARK,Jun Hong PARK,Ji Eun LEE,Seok Kee YOON,Yu Jeong KIM,Tack Oon OH,Tae Keun CHO
申请号：
US14907537
公开号：
US20160361278A1
申请日:
2014.07.25
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to a combination formulation containing metformin for treating non-insulin-dependent diabetes and an HMG-CoA reductase inhibitor for treating dyslipidemia. The present invention provides a combination formulation and a method for preparing the combination formulation, wherein the combination formulation contains metformin and an HMG-CoA reductase inhibitor, and has effectively improved stability by blocking physical and chemical reactions between the active ingredients while securing the stable release of respective active ingredients.
